Advertisement
Screener

XENON PHARMACEUTICALS INC. (XENE) Executive Pay versus Performance: Pay versus Performance

XENON PHARMACEUTICALS INC. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Mr. Mortimer; PEO total compensation $9.22M; PEO compensation actually paid $11.49M; Other NEO average total compensation $3.57M.
  • 2024-12-31: PEO Mr. Mortimer; PEO total compensation $9.80M; PEO compensation actually paid $4.35M; Other NEO average total compensation $4.14M.
  • 2023-12-31: PEO Mr. Mortimer; PEO total compensation $10.12M; PEO compensation actually paid $13.87M; Other NEO average total compensation $3.06M.
  • 2022-12-31: PEO Mr. Mortimer; PEO total compensation $9.23M; PEO compensation actually paid $13.95M; Other NEO average total compensation $3.18M.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Mr. Mortimer$9.22M$11.49M$3.57M$3.56M$291.00$120.00-$345.91M2026-04-22
2024-12-31Mr. Mortimer$9.80M$4.35M$4.14M$2.30M$255.00$91.00-$234.33M2026-04-22
2023-12-31Mr. Mortimer$10.12M$13.87M$3.06M$4.11M$299.00$92.00-$182.39M2026-04-22
2022-12-31Mr. Mortimer$9.23M$13.95M$3.18M$3.66M$256.00$89.00-$125.37M2026-04-22
2021-12-31Mr. Mortimer$1.97M$3.76M$203.00$99.00-$78.88M2026-04-22
2024-12-31Mr. Mortimer$9.80M$4.35M$4.14M$2.30M$299.00$114.00$234.33M2025-04-24
2023-12-31Mr. Mortimer$10.12M$13.87M$3.06M$4.11M$351.00$115.00$182.39M2025-04-24
2022-12-31Mr. Mortimer$9.23M$13.95M$3.18M$3.66M$301.00$111.00$125.37M2025-04-24
2021-12-31Mr. Mortimer$1.97M$3.76M$238.00$125.00$78.88M2025-04-24
2020-12-31Dr. Pimstone$2.94M$3.96M$1.44M$1.84M$117.00$126.00$28.84M2025-04-24
2023-12-31Mr. Mortimer$10.12M$13.87M$3.06M$4.11M$351.00$115.00$182.39M2024-04-26
2022-12-31Mr. Mortimer$9.23M$13.95M$3.18M$3.66M$301.00$111.00$125.37M2024-04-26
2021-12-31Mr. Mortimer$1.97M$3.76M$238.00$125.00$78.88M2024-04-26
2020-12-31Dr. Pimstone$2.94M$3.96M$1.44M$1.84M$117.00$126.00$28.84M2024-04-26
2022-12-31Mr. Mortimer$3.18M$3.66M$301.00$111.00$125.37M2023-04-27
2021-12-31Mr. Mortimer$1.97M$3.76M$238.00$125.00$78.88M2023-04-27
2020-12-31Dr. Pimstone$1.44M$1.84M$117.00$126.00$28.84M2023-04-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Organon & Co. (OGN)United States$3.603B17.03
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09